HOME › DRUGS › METRELEPTIN
ACTIVE SUBSTANCE / INN

METRELEPTIN

Brand name(s): Myalepta, MYALEPT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Lipodystrophy, Familial Partial
BLA125390
ACTIVE SUBSTANCE
Metreleptin
REGULATORS
FDA · EMA
SPONSORS / MAH
Chiesi Farmaceutici S.p.A., CHIESI FARMACEUTICI SPA
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MYALEPTBLA125390CHIESI FARMACEUTICI SPAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MyaleptaChiesi Farmaceutici S.p.A.Authorised30/07/2018Lipodystrophy, Familial Partial

FULL INTELLIGENCE ON METRELEPTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →